CollPlant Biotechnologies Ltd CLGN
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1993-09-01
CollPlant Biotechnologies Ltd statistics & valuation
Market cap$4.8M
P / S2.0×
P / B0.8×
Net margin-484.6%
Return on equity-188.9%
FCF margin-398.4%
Return on capital-141.5%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | 64.8% | -215.5% | 81.8% | -33.8% | 87.2% | 51.1% | 18.9% |
| Operating margin | -484.3% | -3349.7% | -68.5% | -5718.1% | 0.4% | -91.2% | -329.2% |
| Net margin | -484.6% | -3225.0% | -64.0% | -5660.5% | 1.5% | -94.1% | -481.6% |
| FCF margin | -398.4% | -2830.3% | -33.9% | -5007.4% | 6.9% | -79.6% | -310.4% |
| Return on assets | -106.5% | -88.8% | -20.6% | -44.8% | 0.5% | -53.3% | -103.8% |
| Return on equity | -188.9% | -123.3% | -24.8% | -52.4% | 0.5% | -129.0% | -273.1% |
| Debt / equity | — | — | — | — | 0.00× | 0.00× | 0.02× |
| Current ratio | 2.53 | 4.44 | 8.62 | 10.20 | 14.96 | 1.68 | 1.46 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.